Epigenetic modifications and gene expression in cancerogenesis
Journal Title: Annales Academiae Medicae Silesiensis - Year 2018, Vol 72, Issue
Abstract
Epigenetic modifications are changes which can regulate gene expression. DNA methylation in gene promoter regions is the most well-known change among epigenetic modifications. The family of DNA methyltransferases is responsible for DNA methylation. Methylation is reversible due to the demethylation reaction, executed by TET proteins. DNA hypomethylation and hypermethylation of gene promoter regions rich in CpG islands belonging to epigenetic mechanisms commonly occur in many tumors. The epigenetic mechanism of malignant transformation is related not only to changes in the level of methylation of oncogenes or tumor suppressor genes, but also to posttranslational modifications of histone proteins, forcing changes in the chromatin structure. Certain modifications, such as methyation, acetylation, phosphorylation, ubiquitination, biotinylation, ADP–ribosylation, and sumoylation may affect chromatin condensation, protein and enzyme complexes that determine the availability of DNA, which then affects the condensation, replication, recombination and repair processes, as well as gene expression. Among the modulatory mechanisms of the expression of genes involved in the processes leading to cancer development, two main types of small interfering RNA play an important role: siRNA and miRNA. Research data Show that epigenetic mechanisms are involved in the processes leading to tumor development, and searching for epigenetic biomarkers may be useful in epigenetic cancer therapy.
Authors and Affiliations
Marta Poczęta, Ewa Nowak, Dominik Bieg, Ilona Bednarek
Treatment of a forearm cut wound using localised hyperbaric oxygen therapy – a case report
The treatment of hard-to-heal wounds is still a serious interdisciplinary medical problem. In recent years, modern methods of physical medicine have been increasingly and successfully used to treat diseases and traumas o...
Jakość życia pacjentów w trakcie leczenia lekami cytostatycznymi w chorobach nowotworowych krwi
WSTĘP: Choroba nowotworowa i leczenie za pomocą leków cytostatycznych niesie ze sobą szereg negatywnych doznań, emocji oraz skutków ubocznych. W opiece nad pacjentem onkologicznym jakość życia pozostaje w silnej zależnoś...
The influence of rs2273773 and rs7895833 SIRT1 gene polymorphisms on life expectancy in context of metabolic factors in Silesian population
INTRODUCTION: Currently, increasingly more genetic variants with an influence on longevity are being sought. One of these is the SIRT1 gene which codes proteins called sirtuins. Regulating transcription, maintaining geno...
Systemy automatycznej dystrybucji leków (unit dose) w szpitalach w Polsce oraz w wybranych krajach świata
Implementowanie automatycznych i informatycznych technologii w medycynie i farmacji może zredukować liczbę błędów medycznych. Nowoczesnymi technologiami, pozwalającym ich uniknąć, są system automatycznego dozowania leków...
Mukowiscydoza a ciąża – przegląd piśmiennictwa
Mukowiscydoza jest chorobą autosomalną recesywną występującą najczęściej wśród rasy kaukaskiej. W Polsce zanotowano około 1500 przypadków choroby, na świecie na mukowiscydozę choruje blisko 70 tys. osób. Z najnowszych ba...